Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Relating therapy for voices (the R2V study): study protocol for a pilot randomized controlled trial

Authors: Mark Hayward, Clara Strauss, Leanne Bogen-Johnston

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Evidence exists for the effectiveness of cognitive behaviour therapy for psychosis with moderate effect sizes, but the evidence for cognitive behaviour therapy specifically for distressing voices is less convincing. An alternative symptom-based approach may be warranted and a body of literature has explored distressing voices from an interpersonal perspective. This literature has informed the development of relating therapy and findings from a case series suggested that this intervention was acceptable to hearers and therapists.

Methods/Design

An external pilot randomized controlled trial (RCT) comparing outcomes for 15 patients receiving 16 hours (weekly sessions of one hour) of relating therapy and their usual treatment with 15 patients receiving only their usual treatment. Participants will be assessed using questionnaires at baseline, 16 weeks (post-intervention), and 36 weeks (follow-up).

Discussion

Expected outcomes will include a refined study protocol and an estimate of the effect size to inform the sample size of a definitive RCT. If evidence from a fully powered RCT suggests that relating therapy is effective, the therapy will extend the range of evidence-based psychological therapies available to people who hear distressing voices.

Trial registration

Current Controlled Trials ISRCTN registration number 44114663. Registered on 13 June 2013.
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (fifth edition). 2013, Arlington, VA: APA
2.
Thomas P, Mathur P, Gottesman II, Nagpal R, Nimgaonkar VL, Deshpande SN: Correlates of hallucinations in schizophrenia: A cross-cultural evaluation. Schizophr Res. 2007, 9: 41-49.CrossRef
3.
Sommer IE, Koops S, Blom JD: Comparison of auditory hallucinations across different disorders and syndromes. Neuropsychiatry. 2012, 2: 1-12. 10.2217/npy.11.75.CrossRef
4.
National Institute for Health and Clinical Excellence (NICE): Schizophrenia: the NICE Guideline on Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care – Updated Edition. National Clinical Guideline Number 82. 2010, London: National Collaborating Centre for Mental Health
5.
Wykes T, Steel C, Everitt B, Tarrier N: Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008, 34: 523-527.CrossRefPubMed
6.
McCarthy-Jones S, Thomas N, Dodgson G, Fernyhough C, Brotherhood E, Wilson G, Dudley R: What have we learnt about the ability of cognitive behavioural therapy to help with voice-hearing?. In Psychological Approaches to Understanding and Treating Auditory Hallucinations: From Theory to Therapy. Edited by: Hayward M, Strauss C, McCarthy-Jones S. 2014, Hove: Routledge
7.
Bentall RP: Madness explained: why we must reject the Kraepelinian paradigm and replace it with a complaint-orientated approach to understanding mental illness. Med Hypotheses. 2006, 66: 220-233. 10.1016/j.mehy.2005.09.026.CrossRefPubMed
8.
Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, Ross K: Cognitive therapy for command hallucinations: randomized controlled trial. Br J Psych. 2004, 184: 312-320. 10.1192/bjp.184.4.312.CrossRef
9.
Hayward M, Berry K, Ashton A: Applying interpersonal theories to the understanding of and therapy for auditory hallucinations: A review of the literature and directions for further research. Clin Psychol Rev. 2011, 31: 1313-1323. 10.1016/j.cpr.2011.09.001.CrossRefPubMed
10.
Hayward M, Berry K, McCarthy-Jones S, Strauss C, Thomas N: Beyond the omnipotence of voices: further developing a relational approach to auditory hallucinations. Psychosis. 2013, doi:10.1080/17522439.2013.839735
11.
Benjamin LS: Is chronicity a function of the relationship between the person and the auditory hallucination?. Schizophr Bull. 1998, 15: 291-310.CrossRef
12.
Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J: The power and omnipotence of voices: Subordination and entrapment by voices and significant others. Psychol Med. 2000, 30: 337-344. 10.1017/S0033291799001828.CrossRefPubMed
13.
Birchwood M, Gilbert P, Gilbert J, Trower P, Meaden A, Hay J, Murray E, Miles JNV: Interpersonal and role-related schema influence the relationship with the dominant ‘voice’ in schizophrenia: a comparison of three models. Psychol Med. 2004, 34: 1571-1580. 10.1017/S0033291704002636.CrossRefPubMed
14.
Birtchnell J: How Humans Relate: A New Interpersonal theory. 1996, Hove: Psychology Press
15.
Hayward M, Denney J, Vaughan S, Fowler D: The voice and you: development and psychometric evaluation of a measure of relationships with voices. Clin Psychol Psychother. 2008, 15: 45-52. 10.1002/cpp.561.CrossRefPubMed
16.
Hayward M, Overton J, Dorey T, Denney J: Relating Therapy for people who hear voices: a case series. Clin Psycho Psychother. 2009, 16: 216-227. 10.1002/cpp.615.CrossRef
17.
Sorrell E, Hayward M, Meddings S: Interpersonal processes and hearing voices: a study of the association between relating to voices and distress in clinical and non-clinical hearers. Beh Cog Psychother. 2010, 38: 127-140. 10.1017/S1352465809990506.CrossRef
18.
Hayward M: Interpersonal relating and voice hearing: to what extent does relating to the voice reflect social relating. Psycho Psychother. 2003, 76: 369-383. 10.1348/147608303770584737.CrossRef
19.
Birchwood M, Michail M, Meaden A, Tarrier N, Lewis S, Wykes T, Davies L, Dunn G, Peters E: Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomized controlled trial. Lancet Psychiatry. 2014, 1: 23-33. 10.1016/S2215-0366(14)70247-0.CrossRefPubMed
20.
Hayward M, Fuller E: Relating therapy for people who hear voices: perspectives from clients, family members, referrers and therapists. Clin Psychol Psychother. 2010, 17: 363-373. 10.1002/cpp.672.CrossRefPubMed
21.
Medical Research Council: A Framework for the Development and Evaluation of RCTs for Complex Interventions to Improve Health. 1998, London: MRC
22.
Julious SA: Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005, 4: 287-291. 10.1002/pst.185.CrossRef
23.
Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999, 29: 879-889. 10.1017/S0033291799008661.CrossRefPubMed
24.
Hayward M, Strauss C, Kingdon D: Overcoming Distressing Voices. 2012, London: Constable and Robinson
25.
Woodward T, Jung K, Hwang H, Yin J, Taylor L, Menon M, Peters E, Kuipers E, Waters F, Lecomte T, Sommes IE, Daalman K, van Lutterveld R, Hubl D, Kindler J, Homan P, Badcock J, Chhabra S, Cella M, Keedy S, Allen P, Mechelli A, Preti A, Siddi S, Erickson S: Symptom dimensions of the Psychotic Symptoms Rating Scale in Psychosis: A multisite study. Schizophr Bull. 2014, Suppl 4: S265-S264.CrossRef
26.
Greenwood K, Sweeney A, Williams S: CHoice of Outcome In Cbt for psychosEs (CHOICE): the development of a new service user-led outcome measure of CBT for psychosis. Schizophr Bull. 2010, 36: 126-135. 10.1093/schbul/sbp117.CrossRefPubMed
27.
Birtchnell J, Hammond S, Horn E, De Jong C, Argyroula K: A cross national comparison of a shorter version of the person’s relating to others questionnaire. Clin Psychol Psychother. 2013, 20: 36-48. 10.1002/cpp.789.CrossRefPubMed
28.
Zigmund AS, Snaith RP: The hospital anxiety and depression scale. Acta Psych Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.CrossRef
29.
Medical Research Council: Guidelines for Good Clinical Practice in Clinical Trials. 1998, London: MRC
Metadata
Title
Relating therapy for voices (the R2V study): study protocol for a pilot randomized controlled trial
Authors
Mark Hayward
Clara Strauss
Leanne Bogen-Johnston
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-325

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue

Study protocol

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial

Study protocol

An experienced physiotherapist prescribing and administering corticosteroid and local anaesthetic injections to the shoulder in an Australian orthopaedic service, a non-inferiority randomised controlled trial and economic analysis: study protocol for a randomised controlled trial

Study protocol

Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial

Study protocol

Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study

Study protocol

Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial

Study protocol

Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes